ZHOU Kai-Yu,ZHU Qi,HUA Yi-Min et al. Successful treatment of fetal atrial flutter and hydrops by maternal administration of oral digoxin: a case report[J]. CJCP, 2009, 11(12): 1023-1024.
[1]Ryuji K, Azusa F, Takako K, Jun M, Machiko N, Yuri T, et al. Changes in digoxin pharmacokinetics treated with lipopolysaccharide in Wistar rats[J]. Biol Pharm Bull, 2008, 31(6):1221-1225.
[2]Dawes M. Drugs in pregnancy. Pharmacokinetics in pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2001, 15(6):819-826.
[5]Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surveillance of fetal hydrops[J]. J Matern Fetal Neonatal Med, 2006, 19(7):407-413.
[6]Huhta JC ,Quintero R, Rubén A, Suh E, Bader, R. Advance in fetal cardiac intervention[J]. Cardiovas Med, 2004, 16(5):487-493.
[7]Kondo T, Kitazawa R, Noda-Maeda N, Kitazawa S. Fetal hydrops associated with spontaneous premature closure of ductus arteriosus[J]. Pathol Int, 2006, 56(9):554-557.
[8]Horikoshi T. Fetal hydrops associated with congenital pulmonary myofibroblastic tumor[J]. J Obstet Gynaecol Res, 2005, 31(6):552-555.